Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients
(Q44130698)
scientific article published in October 2002
scientific article published in October 2002
Language:
Current Data About
Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients
other details
| description | scientific article published in October 2002 |
External Links
| (P356) |
10.1034/J.1600-079X.2002.02943.X
|
| (P698) |
12220335
|